Unlikely to cause harm — often a labeling or packaging issue.
Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay.
| Brand name | CLINDAMYCIN PHOSPHATE |
| Generic name | CLINDAMYCIN PHOSPHATE |
| Active ingredient(s) | CLINDAMYCIN PHOSPHATE |
| Distributed by / for | SUN PHARMACEUTICAL INDUSTRIES INC |
| NDC | 51672-4081-4 |
| Full product label | Clindamycin Phosphate USP, 1% (10 mg/mL), Topical Solution, 60 mL per applicator bottle, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel; Dist. by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC# 51672-4081-4 |
| Recalling firm | SUN PHARMACEUTICAL INDUSTRIES INC |
| Distribution | Nationwide in the USA. |
| Recall initiated | 2025-11-26 |
| Report date | 2026-01-21 |
| Recall completed | — |
| Recall number | D-0257-2026 |
| Classification | Class III |
| FDA status | Ongoing |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗